Sterling Pharmaceuticals Limited

Sterling Pharmaceuticals Ltd, based in Birmingham, UK, is a small, active company founded 17 years ago. With 50 employees and £2,128,311 in assets, it operates from a real address and is managed by two directors and a single owner. The company regularly imports organic chemicals (for 7 months) and exports pharmaceutical products (for 27 months), indicating a focus on both sourcing and distribution within the pharmaceutical sector.

The company’s website reveals Sterling Pharmaceuticals is a Contract Development and Manufacturing Organisation (CDMO), offering services to pharmaceutical and biotech companies. It operates facilities in North Carolina, US; Deeside, UK; Cramlington, UK; Wisconsin, US; Newcastle Biosphere, UK; and Cork, Ireland. Services include drug discovery, early-scale-up, analytical services, small molecule development, API manufacturing, and ADC (antibody-drug conjugate) development. The website highlights a commitment to sustainability, innovation, and a strong company culture.

Financially, Sterling Pharmaceuticals Ltd shows some concerning trends. Creditors increased by a substantial 40%, reaching £520,000, while cash reserves plummeted 30% to £810,000. Bank borrowings, however, vanished entirely, decreasing by a staggering 100% to zero. Net assets increased by 17%, reaching £1.2 million, and net current assets improved by 70%, landing at -£140,000. The company’s small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) helps it remain flexible, but the increase in creditors suggests a potential need to manage cash flow more effectively. There's no auditor mentioned, which is common for small companies.

Overall, Sterling Pharmaceuticals Ltd appears to be a specialized CDMO with a global footprint, but its financial performance warrants close monitoring. The company’s ability to maintain its growth trajectory will depend on its ability to manage its finances and capitalize on the growing demand for outsourced pharmaceutical manufacturing services.

Registered in England/Wales under the registration number 06268419, with a registered address at B12 9DD, United Kingdom, Birmingham, West Midlands, 385 Moseley Rd Moseley.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.